Siemens Healthineers AG provided earnings guidance for the year 2022. For fiscal year 2022, the company expects comparable revenue growth between 0% and 2% from fiscal year 2021. Excluding revenue from rapid COVID-19 antigen tests, the company expects comparable revenue growth between 5% and 7%.
Market Closed -
Other stock markets
|
After market 15:59:00 | |||
54.22 EUR | +2.42% | 54.12 | -0.18% |
05-23 | Ailing hospitals slow down German medical technology sector | DP |
05-22 | SIEMENS HEALTHINEERS : Berenberg maintains a Buy rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.08% | 64.3B | |
+7.32% | 217B | |
+13.83% | 194B | |
+20.48% | 143B | |
+31.33% | 111B | |
+14.64% | 52.94B | |
+2.72% | 49.53B | |
-5.88% | 38.31B | |
+0.25% | 35.22B | |
+22.76% | 30.47B |
- Stock Market
- Equities
- SHL Stock
- News Siemens Healthineers AG
- Siemens Healthineers AG Provides Earnings Guidance for the Year 2022